These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 29200755)

  • 21. Stem Cell Therapy for Epidermolysis Bullosa-Does It Work?
    Tamai K; Uitto J
    J Invest Dermatol; 2016 Nov; 136(11):2119-2121. PubMed ID: 27772543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stem cell therapies for wound healing.
    Kosaric N; Kiwanuka H; Gurtner GC
    Expert Opin Biol Ther; 2019 Jun; 19(6):575-585. PubMed ID: 30900481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ex vivo stem cell gene therapy of the skin : Ready for clinical use?].
    Koller U
    Hautarzt; 2020 Feb; 71(2):85-90. PubMed ID: 31965203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expediting the study on the role of stem cells in wound treatment].
    Hu DH
    Zhonghua Shao Shang Za Zhi; 2010 Aug; 26(4):247-50. PubMed ID: 21029678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potential of umbilical cord blood multipotent stem cells for nonhematopoietic tissue and cell regeneration.
    van de Ven C; Collins D; Bradley MB; Morris E; Cairo MS
    Exp Hematol; 2007 Dec; 35(12):1753-65. PubMed ID: 17949892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesenchymal stromal cells: properties and role in management of cutaneous diseases.
    Kim KH; Blasco-Morente G; Cuende N; Arias-Santiago S
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):414-423. PubMed ID: 27549663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa.
    Conget P; Rodriguez F; Kramer S; Allers C; Simon V; Palisson F; Gonzalez S; Yubero MJ
    Cytotherapy; 2010 May; 12(3):429-31. PubMed ID: 20230217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of adipose-derived stem cells in wound healing.
    Hassan WU; Greiser U; Wang W
    Wound Repair Regen; 2014; 22(3):313-25. PubMed ID: 24844331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards a gene therapy clinical trial for epidermolysis bullosa.
    Ferrari S; Pellegrini G; Matsui T; Mavilio F; De Luca M
    Rev Recent Clin Trials; 2006 May; 1(2):155-62. PubMed ID: 18473966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 28. Embryonic and adult stem cell therapy.
    Henningson CT; Stanislaus MA; Gewirtz AM
    J Allergy Clin Immunol; 2003 Feb; 111(2 Suppl):S745-53. PubMed ID: 12592319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rescue of the mucocutaneous manifestations by human cord blood derived nonhematopoietic stem cells in a mouse model of recessive dystrophic epidermolysis bullosa.
    Liao Y; Ivanova L; Zhu H; Yahr A; Ayello J; van de Ven C; Rashad A; Uitto J; Christiano AM; Cairo MS
    Stem Cells; 2015 Jun; 33(6):1807-17. PubMed ID: 25640200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential mesenchymal stem cell therapy for skin diseases.
    Li X; Hamada T; Ohata C; Furumura M; Hashimoto T
    Exp Dermatol; 2013 Aug; 22(8):515-6. PubMed ID: 23879810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidermal Stem Cells in Skin Wound Healing.
    Li Y; Zhang J; Yue J; Gou X; Wu X
    Adv Wound Care (New Rochelle); 2017 Sep; 6(9):297-307. PubMed ID: 28894637
    [No Abstract]   [Full Text] [Related]  

  • 34. Preconditioning of mesenchymal stem cells for improved transplantation efficacy in recessive dystrophic epidermolysis bullosa.
    Perdoni C; McGrath JA; Tolar J
    Stem Cell Res Ther; 2014 Nov; 5(6):121. PubMed ID: 25376815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stem cell therapy in dermatology.
    Khandpur S; Gupta S; Gunaabalaji DR
    Indian J Dermatol Venereol Leprol; 2021; 87(6):753-767. PubMed ID: 34245532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells - a review.
    Bacakova L; Zarubova J; Travnickova M; Musilkova J; Pajorova J; Slepicka P; Kasalkova NS; Svorcik V; Kolska Z; Motarjemi H; Molitor M
    Biotechnol Adv; 2018; 36(4):1111-1126. PubMed ID: 29563048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adipose-derived stem cells for tissue repair and regeneration: ten years of research and a literature review.
    Mizuno H
    J Nippon Med Sch; 2009 Apr; 76(2):56-66. PubMed ID: 19443990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Making surrogate β-cells from mesenchymal stromal cells: perspectives and future endeavors.
    Bhonde RR; Sheshadri P; Sharma S; Kumar A
    Int J Biochem Cell Biol; 2014 Jan; 46():90-102. PubMed ID: 24275096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adult Stem Cells for Regenerative Therapy.
    Gurusamy N; Alsayari A; Rajasingh S; Rajasingh J
    Prog Mol Biol Transl Sci; 2018; 160():1-22. PubMed ID: 30470288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generalized atrophic benign epidermolysis bullosa in 2 siblings complicated by multiple squamous cell carcinomas.
    Swensson O; Christophers E
    Arch Dermatol; 1998 Feb; 134(2):199-203. PubMed ID: 9487212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.